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ATP     Adenosinetriphosphate 
CD3      T cell surface glygoprotein cd3 
CD4      T cell surface glygoprotein cd4 
CD8     T cell surface glygoprotein cd8 
CD25     Interleukin-2 receptor α (IL-2Rα) 
CD44      Phagocytic glycoprotein-1 (pgp-1) 
CD117     Stem cell factor receptor (c-kit)  
cDNA     Complementary deoxyribonucleic acid  
C/EBP     CCAAT enhanser binding protein 
ChIP      Chromatin immunoprecipitation  
c-kit     CD117 
CLB      Cell lysis buffer  
Ct      Threshold cycle 
CTP     Cytidine triphosphate  
DNA     Deoxyribonucleic acid  
DP     Double positive  
Egr     Early growth response element 
GATA-3    GATA binding protein 
GTP      Guanosine triphosphate 
HBSS      Hank’s Balanced Salt Solution 
H3K9      Lysine 9 of Histone 3  
H3K4     Lysine 4 of Histone 4 
MHC      Major histocompatibility complex 
mRNA    Messanger ribonucleic acid 
NBD      Nonamer binding domain  
Pax-5      Paired box gene 5 
PBS      Phosphate buffered saline 
QRT-PCR    Real time quantitative RT-PCR 
RAG1     Recombination activating gene 1 
RAG2     Recombination activating gene 2 
RNA      Ribonucleic acid 
RSS     Recombination signal sequence 
RT-PCR     Reverse transcriptase polymerase chain reaction 
sca-1      Stem cell antigen 1 
SLO      Streptolysin O 
TCR     T cell receptor 
Thy-1     Thymus cell antigen 1 
TE      Tris-EDTA  
TN     Triple negative      




Cells and cell lines 
 
ASC      Human adipose stem cells     
EC      Human Embryonal carcinoma 
INS-1E    Rat insulinoma cell line INS-IE  
Jurkat      Human T lymphocyte cell line 
293T      Human kidney epithelial cell line 
 
Gene names  
 
Brg1     Brahma-related gene 1 
GAPDH    Glyceraldehyde-3-phosphatedehydrogenase 
IL2     Interleukin 2 
Oct-4     Octamer-4, a POU family transcription factor 
RAG1     Recombination activating gene 1 





















This thesis reports an in vitro reprogramming approach with pig thymocyte extracts to 
induce expression of two lymphoid-specific recombination activating enzyme genes, RAG1 
and RAG2, in human kidney epithelial 293T cells. RAG2 was upregulated in extract-treated 
cells 8 days after extract treatment, suggesting that some functional changes may have 
taken place in 293T cells exposed to thymocyte extract. RAG2 upregulation was detected 
in high (22mg/ml) protein concentration thymocyte extract-treated cells. However, induced 
expression of RAG2 was transient and decreased to basic level within 23 days. This 
transient expression might be explained by the nature of RAG expression in vivo, or it 
might indicate, most likely, incomplete reprogramming.  Furthermore, upregulation of 
RAG2 was not accompanied by RAG1 expression or changes in morphology and growth 
pattern of 293T cells. Thus, we conclude that although RAG2 upregulation is observed in 
extract-treated cells, further work is required to establish a proof-of-concept that RAG 
enzyme-initiated T cell receptor gene rearrangement can be manipulated experimentally in 











Cell differentiation is a regulated process by which cells become committed to perform 
specific functions while loosing ability to perform others. Differentiation is accompanied 
by changes in chromatin structure, nuclear organization and gene expression. At least 200 
distinct cell types have been identified in the human body. These cells collaborate with one 
another to form various tissues. Most tissues, such as bone marrow, skin, liver, brain, blood 
and adipose tissue, contain not only differentiated, specialized, cells, but also more 
pluripotent cells with stem cell properties. These so-called somatic stem cells are believed 
to be responsible for tissue homeostasis. Somatic stem cells divide to produce two daughter 
cells, of which the one will differentiate into a specific cell type, while the other daughter 
cell retains the stem cell function and contributes to maintaining the stem cell population. 
Somatic stem cells possess some degree of pluripotency and are able to give rise to several 
cell types. For example, bone marrow stromal stem cells can give raise to bone, fat, 
cartilage and fibrous connective tissue (Pittenger et al., 1999). Bone marrow contains 
another class of stem cells, the hematopoietic stem cells, which form all blood cell types in 
the body (Gunsilius et al., 2001; Weissman, 2000). Hematopoietic stem cells also give rise 
to specific types of progenitor cells, called thymocytes. These non-T cell lineage 
committed progenitors migrate from the bone marrow to the thymus where they 
differentiate into mature T lymphocytes (see below). 
 Evidence from nature and from experimental studies proposes that cell fate is not 
locked, but can in some instances be altered. This thesis explores the possibility of whether 
a non-T-cell type (such as an epithelial cell) can be instructed (or reprogrammed) to take 
on T-cell functions. An example of long term medical benefits of reprogramming a non-T 
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cell into a functional lymphocyte would be to enhance the immune system of cancer 
patients with low level of lymphocytes as a result of chemotherapy. 
 
The thymus and thymic function 
The thymus is our second primary lymphoid organ, located in the thorax just above the 
heart in humans (see Figure 1.). The thymus is a two-lobe organ, consisting of epithelial 
cells organized into a three-dimensional meshwork. Vertebrate thymus organogenesis 
depends on interactions of cells from all three germ layers, but the molecular mechanisms 
involved are not well established (Manley, 2000). The thymus undergoes morphological 
changes during life, being largest and most active at puberty, and regressing while being 
replaced largely by adipose tissue. 
The thymus provides a microenvironment essential for T cell development. 




Figure 1. The thymus. Thymus is a complex 
epithelial organ located in upper chest cavity in 
humans. The thymus provides a 
microenvironment essential for T cell 
development. T cell precursors arise from bone 
marrow and migrate to thymus, where the 
combination of cellular interactions, cytokines 
and chemokines induce these progenitors (also 
called thymocytes) to undergo differentiation 
program leading to development of functional 









to the thymus where they undergo highly specific maturation and selection processes to 
differentiate into T cells (also called T lymphocytes). While in the thymus, these 
progenitor cells are referred to thymocytes. During maturation of thymocytes into T cells, 
thymic epithelial cells secrete peptide factors (interleukins, thymosins, thymopoietin and 
thymulin) that influence T cell development. T cells that have successfully undergone all 
differentiation and selection processes are exported from the thymus and migrate to 
peripheral lymphoid sites. 
 
T cell development 
As thymocytes differentiate into T cells in the thymus, they start to synthesize T cell 
receptor (TCR) proteins and insert them into the plasma membrane. The T cell receptor is a 
heterodimeric (αβ or γδ) membrane bound receptor that helps initiate immune responses by 
recognizing fractions of antigens presented by major histocompatibility complex (MHC) 
proteins on the surface of antigen-presenting cells. During T cell development, TCR α, β, γ 
and δ genes are assembled from germ line V, D and J gene segments by a site-specific 
recombination reaction (called the V(D)J recombination) to compose functional TCRαβ or 
TCRγδ loci (Gellert, 1992; Tonegawa, 1983).   
 T-cell progenitors arise from bone marrow and migrate into the thymus. Although 
the multipotential nature of these early intrathymic progenitors is not well defined, it is 
generally accepted that the first stage of lineage commitment occurs prior to or 
immediately after thymic colonization. The earliest intrathymic progenitors cells exhibit a 
CD4lo, CD44+, Thy-1-,sca-1+-, c-kit+ phenotype (Wu et al., 1991). These cells are not 
committed to the T cell lineage and retain the ability to differentiate into natural killer 
cells, dentritic cells, T cells or B cells (Ardavin et al., 1993; Matsuzaki et al., 1993; Moore 
and Zlotnik, 1995; Wu et al., 1996).  The CD4lo cells are referred as triple negative cells 
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(TN), as they lack expression of CD3, CD4 and CD8 antigens (CD3-, CD4-, CD8-). TN 
cells can further be subdivided according to expression of other cell surface markers (e.g., 
CD44, CD25, CD117). The TCR genes in CD4lo TN cells are shown to be in a germ line 
configuration (Wu et al., 1991), indicating that no rearrangement of TCR genes have taken 
place.  
At the TN stage, cells begin to increase in size and rearrange their β, γ and δ-chains, 
leading to irreversible T cell lineage commitment (Bhandoola and Sambandam, 2006; Gill 
et al., 2003). The expressed TCRβ-chain combines with pre-TCRα-chain (encoded by non-
rearranged alpha loci) and with a collection of proteins (the CD3/ζ complex) on the cell 
(Groettrup et al., 1993; Saint-Ruf et al., 1994). Thymocytes that have undergone 
productive TCR β-chain rearrangements are selected for further maturation (by β-
selection) (Wiest et al., 1999). Cells emerging from β-selection start to express the cell 
surface markers CD4 and CD8, leading to double positive (DP) stage cells (CD4+, CD8+), 
and to rearrangement of the TCRα chain loci to produce the second component of the 
mature TCRαβ, the α-chain. Transition to the DP stage is promoted by the Egr family of 
transcriptional factors (Carleton et al., 2002) and is followed by a burst in proliferation. It 
is estimated that 90% of the lymphoid cells in the thymus of a young individual consist of 
immature DP TCRαβ-expressing cells.  
After the transition to the DP stage, thymocytes undergo highly specific selection 
processes whereby cells that cannot produce a functional TCR are removed. Cells that are 
unable to recognize self-peptides die by neglect, while cells that recognize self-peptide-
MHC are chosen for maturation by positive selection. Furthermore, cells that respond with 
too high affinity to self-peptides are deleted by negative selection. Thus, these selection 
processes ensure that mature T-lymphocytes are able to recognize and react against a wide 
variety of foreign molecules, although they are still not self-reactive. During thymic T-cell 
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development, it is estimated that ~95% of thymocytes are lost by these selection processes 
(Scollay et al., 1980). Cells that have successfully undergone thymic maturation to single 
positive (CD4+ or CD8+) cells are exported from thymus at a constant rate of 1-2% of total 
thymocytes per day. The exported cells mainly home into lymph nodes, the spleen and 
Peyer’s patches (Scollay et al., 1980). 
 
RAG1 and RAG2 
The V(D)J recombination (where VDJ stands for variable, diversity and joining, 
respectively) is a site-specific recombination where the antigen receptors of T and B cells 
are created from V, D and J gene segments (Gellert, 1992; Tonegawa, 1983). The 
lymphoid-specific recombination activating genes RAG1 and RAG2 code for proteins 
essential for TCR synthesis by enabling V(D)J recombination (Oettinger et al., 1990). 
RAG1 and RAG2 are conserved between variety of species that carry out V(D)J 
recombination (Oettinger et al., 1990; Schatz et al., 1989). Furthermore, Rag1- or Rag2-
deficient mice have shown not to develop mature lymphocytes and are immune-deficient, 
illustrating the importance of the RAG genes for lymphocyte development and 
establishment of a functional immune system (Mombaerts et al., 1992; Shinkai et al., 
1992). 
 
RAG1 and RAG2 mediate V(D)J recombination 
RAG1 and RAG2 are the core components of the DNA recombinase that mediates the 
V(D)J recombination of TCR genes in T (and B) lymphocytes. Purified RAG1 and RAG2 
alone are able to mediate recombination (McBlane et al., 1995). RAG1 and RAG2 direct 
DNA cleavage by recognizing recombination signal sequences (RSS) that flank the V, D 
and J gene segments of the TCR locus, creating double strand breaks at the border of the 
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RSS and coding flank (see Figure 2). This RAG-mediated cleavage occurs in a synaptic 
complex of two RSSs (Hiom and Gellert, 1997; van Gent et al., 1995). An RSS is 
composed of a conserved heptamer and nonamer separated by a spacer of either 12 or 23 
base pairs. An efficient recombination occurs only between a 12-bp RSS and a 23-bp RSS 
(Tonegawa, 1983). Furthermore, RAG1 and RAG2 complexes are suggested to have the 
ability to recognize and open the hairpin coding ends that is important for the generation of 
junctional diversity during V(D)J recombination (Besmer et al., 1998; Shockett and Schatz, 
1999). 
 
Figure 2. Schematic representation of the 
V(D)J recombination process. The white and 
grey circles represent the RAG1 and RAG2 
proteins, and hatched boxes identify the 
Recombination Signal Sequences (RSS). 
RAG1 recognizes the RSS after which RAG2 
is recruited and RAG protein complex is 
formed. The RAG1/RAG2 complex directs the 
DNA cleavage at the border of the RSS and the 
coding flank, leading to formation of blunt 
signal ends and hairpin coding ends.  






RAG1 and RAG2 expression and regulation 
 In developing thymocytes, Rag-1 and Rag-2 are expressed in two waves which correlate 
with the rearrangement of TCR α and β chains (Wilson et al., 1994). First, RAG1 and 
RAG2 expression is induced at the triple negative (TN) stage, leading to TCR β-chain 
rearrangement. Expressed TCR-β chains combine to pre-TCR with CD3/ζ proteins, which 
leads to downregulation of the RAG1 and RAG2 genes. Induction of cell surface marker 
CD4 and CD8 expression leads to the transition of cells to the DP stage, where RAG1 and 
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RAG2 expression is reinduced and TCR α-chain is rearranged. This RAG1 and RAG2 
expression is not terminated until positive selection takes place. Although little is known 
about the regulation of RAG1 and RAG2 gene expression, RAGs can be downregulated 
both through specific stimuli (antigen presented by MHC molecules) (Brandle et al., 1992), 
and by non-specific stimuli, such as TCR cross-linking and treatment by phorbol esters 
(Turka et al., 1991). Regulation of chromatin structure and additional control elements 
outside promoter region has been shown to be responsible for tissue- and stage-specific 
expression of RAGs (Kitagawa et al., 1996; Kurioka et al., 1996; Wei et al., 2002). 
 
Natural cell plasticity 
Differentiated cells have long been thought to be committed to their fate, which is 
determined by their developmental history. However, there is natural and experimental 
evidence to indicate that cell type switching through both dedifferentiation and 
transdifferentiation processes can take place. Dedifferentiation refers to a process where 
differentiated cells progress towards a less differentiated state. Dedifferentiation is 
characterized by a loss of differentiation markers and a subsequent gain of proliferative 
capacity (Soll and Waddell, 1975; Takeuchi and Sakai, 1971). Transdifferentiation refers 
to the conversion of one differentiated cell type into another differentiated cell type (Tosh 
and Slack, 2002; Slack and Tosh, 2001). 
 
Natural dedifferentiation 
Classical evidence of dedifferentiation occurring in nature comes from urodele 
amphibians. In response to injury or damage, an adult newt can replace its limbs, jaws, lens 
and large sections of heart (Brockes and Kumar, 2002; Tosh and Slack, 2002). 
Furthermore, the outcome seems to depend on the plasticity (change in cell behaviour or 
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cell type in response to environmental cues) of differentiated cells that remain after tissue 
removal. After amputation of the limb, for example, differentiated cells localized to the 
zone of injury or amputation surface dedifferentiate and become blastemal cells 
(progenitor cells of the regenerate). These cells divide to form a blastema (a mesenchymal 
growth zone) and give rise to a new limb by a process of proliferation, differentiation and 
morphogenesis (reviewed in Brockes and Kumar, 2002; Tsonis, 2000). 
 Limb regeneration ability is limited in mammals. In contrast to urodele amphibian 
organ regeneration, mammalian regeneration generally utilizes pre-existing stem cells that 
differentiate to specific cell types (Carlson, 2005). However, there are sporadic instances 
of regeneration in mammals that show similarities to regeneration processes observed in 
amphibians. An example is ear hole closure in healer MRL mice (in contrast to non-healer 
BG mice), where similarities in mammalian and amphibian regeneration are seen at the 
histological and gene expression levels (Clark et al., 1998; Heber-Katz, 1999). Moreover, 
as regeneration involves replacement and restoration of adult tissue mass with normal 
architecture and function, the healer MRL mouse displays a capacity to attain full closure 
of ear punches with normal tissue architecture. No scar tissue formation is observed, as 
would be expected in the case of wound repair (Heber-Katz, 1999). Thus, ear hole closure 
is a form of regeneration (Clark et al., 1998; Heber-Katz, 1999). 
 
Naturally occurring transdifferentiation 
Evidence of naturally occurring transdifferentiation can be observed in insects, amphibians 
and in many vertebrates (Slack and Tosh, 2001). In mammals, a well-documented example 
of transdifferentiation is the appearance of hepatocytes in the pancreas of rats in response 
to treatments such as a copper deficient diet (Rao et al., 1988; Rao et al., 1989; Reddy et 
al., 1991). Copper deficiency has been shown to cause an irreversible depletion of over 
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80% of the acinar cells in the pancreas, combined with differentiation of hepatocytes from 
pancreatic ductular cells and interstitial cells (Rao et al., 1988; Rao et al., 1989; Reddy et 
al., 1991). Furthermore, pancreatic hepatocytes express several liver-specific genes, such 
as Albumin and Urate oxidase (Rao et al., 1988; Rao et al., 1989; Reddy et al., 1991). 
Another example of transdifferentiation is lens regeneration in amphibians after surgical 
removal (reviewed in Tosh and Slack, 2002; Tsonis, 2000). After lens removal, pigmented 
cells of the iris become depigmented and proliferate to form a new lens indistinguishable 
from the original (Tosh and Slack, 2002; Tsonis, 2000). 
 
Experimental manipulations of cell fate 
Evidence of cell plasticity in nature has led to experimental efforts to induce 
dedifferentiation and transdifferentiation of somatic cells in the laboratory. Changing the 
fate of a differentiated cell involves a reprogramming of the transcriptional program of that 
cell. Several lines of evidence indicate that cell fate can, at least to some extent, be 
manipulated – or reprogrammed. These reprogramming approaches include transplantation 
of a somatic nucleus into an enucleated egg, cell hybridization, and treatment with 
cytoplasmic and nuclear extracts prepared from a chosen “target” cell type.  
 
Manipulation of cell function by nuclear transplantation 
Perhaps the clearest evidence of nuclear reprogramming emanates from nuclear 
transplantation of somatic nuclei in to unfertilized oocytes and the birth of resulting cloned 
offspring. Injection of somatic nucleus of an adult Xenopus laevis into a Xenopus egg 
showed to yield normal hatched tadpoles (Gurdon, 1962). Similarly, Xenopus laevis 
somatic nuclei transplanted into a newt oocyte are also reprogrammed, as shown by the 
activation of genes normally inactive in somatic cells but active in early embryos (De 
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Robertis and Gurdon, 1977). Furthermore, permeabilized mammalian thymocyte nuclei 
can be reprogrammed after injection into Xenopus oocytes: injection was followed by 
induction of a pluripotency marker (oct-4) and down regulation of a differentiation marker 
(thy-1), demonstrating the transcriptional specificity of reprogramming (Byrne et al., 
2003). DNA demethylation of the oct-4 promoter was shown to be necessary for induction 
of Oct-4 expression in these nuclei (Simonsson and Gurdon, 2004). 
Several mammalian species have been cloned successfully from an adult somatic 
donor cell nuclei transplanted into unfertilized oocytes (Cibelli et al., 1998; Polejaeva et 
al., 2000; Wakayama et al., 1998; Wilmut et al., 1997). Nevertheless, mammalian cloning 
remains highly inefficient to date, as most reconstructed embryos fail to develop beyond 
implantation (Cibelli et al., 2002). This argues that complete functional reprogramming of 
somatic nuclear function, even through nuclear transplantation, remains a challenging 
issue. 
 
Manipulation of nuclear function by cell fusion 
Cell fusion experiments have provided evidence to indicate the reprogramming a somatic 
genome could be possible by placing a somatic nucleus into a distinct cellular environment 
(Blau and Blakely, 1999). In the late 1960s, cells were fused to create intra- and inter-
species hybrids with separate nuclei; as such, these hybrids qualified as heterokaryons 
(Harris and Watkins, 1965). Fusion of human differentiated cells with chick erythrocytes 
created heterokaryons in which the chick nuclei was observed to swell and resume 
transcription to code for human proteins (Ringertz et al., 1971). Additionally, human 
muscle genes have been shown to be turned on in human skin cells (Blau et al., 1983) and 
hepatocytes (Miller et al., 1988) fused to myocytes. Therefore, studies involving somatic 
cell hybrids have provided evidence that cell fusion can alter cell fate. Importantly, the 
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creation of non-dividing heterokaryons showed that cell fate could be changed in absence 
of DNA replication or cell division (Blau and Blakely, 1999). These observations indicate 
that the ability to alter cell fate requires interaction of trans-acting molecules brought 
together by the cell fusion process. Interestingly, fusions of a differentiated cell with 
various stem cell types have further shown that epigenetic reprogramming, including DNA 
demethylation and histone modifications, can take place in the somatic nuclei (Kimura et 
al., 2004; Tada et al., 1997; Tada et al., 2001).  
 Functional and medical evidence for mammalian cell fusion in vivo has emerged 
from transplantation studies. Bone marrow cells transplanted into lethally irradiated Mdx 
mice (a mouse model of Duchenne muscular dystrophy) was shown to fuse with skeletal 
muscle myofibers (Gussoni et al., 2002). Furthermore a mouse with mutations in the 
Fumarylacetoacetate hydrolase gene that cause liver failure was observed to regain liver 
function and form regenerative normal liver nodules after transplantation of bone marrow 
cells, indicating fusion of donor bone marrow cells with host hepatocytes (Vassilopoulos et 
al., 2003). 
 
Reprogramming with cell-free extracts 
Nuclear transplantation and cell fusion approaches have been valuable in establishing 
proof of concept that differentiated cell nuclei could be reprogrammed. However, these 
systems are not readily amenable to manipulations for altering reprogramming conditions 
and identifying factors involved in nuclear reprogramming. Indications that nuclear and 
cytoplasmic factors from one cell type are capable of reprogramming the gene expression 
pattern and epigenetic status of the genome of another cell type led to cell extract-based 
reprogramming approaches (see Figure 3). Nuclear and cytoplasmic extracts prepared from 
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a “target” cell type are believed to contain regulatory factors essential to establish the 
transcriptional program specific for the “target” cell.  
  
Figure 3. Schematic illustration of reprogramming system. Permeabilized donor cells are incubated in 
extract of target cell type and cell membranes are resealed with CaCl2 containing complete medium. Extract-
treated cells are cultured further and investigated for changes in transcriptional program. (Modified from 
Collas and Håkelien, 2003). 
 
 
Extract from egg, embryos and various somatic cells have been developed to 
reproduce some aspects of nuclear function in vitro, and to manipulate and identify factors 
essential for nuclear reprogramming. The dynamics of the nuclear envelope and 
chromosomes at mitosis or at fertilization has been reproduced in extracts of Xenopus eggs 
(Lohka and Maller, 1985; Wilson and Newport, 1988), sea urchin eggs (Cameron and 
Poccia, 1994; Collas and Poccia, 1995), Drosophila embryos (Ulitzur et al., 1997), clam 
oocytes (Longo et al., 1994) and mammalian mitotic cells (Burke and Gerace, 1986; Collas 
et al., 1999). Extracts can also be used to perform nuclear functions such as DNA 
replication and transcription (Harish et al., 2001; Martins et al., 2003; Wang et al., 1995). 
Moreover, Xenopus egg extracts have been used to identify some of the molecules 
involved in adenosine trisphosphate (ATP)-dependent chromatin remodelling (Kikyo et al., 
2000).  
Cellular extracts have also been used to reprogram gene expression of somatic cells 
and nuclei. An illustration of dedifferentiation comes from the use of extracts of 
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regenerating newt limbs (McGann et al., 2001). After exposure to extract prepared from 
regenerating newt limbs, terminally differentiated murine myocytes were shown to re-enter 
the cell cycle and to downregulate muscle markers (McGann et al., 2001). Furthermore 
extracts from Xenopus eggs and early embryo have shown to promote upregulation of two 
pluripotency markers (OCT4 and germ cell alkaline phosphatase) in 293T cells and 
leukocytes (Hansis et al., 2004). Moreover, the 293T cells showed downregulation of 
natriuretic peptide receptor and kidney markers (Hansis et al., 2004). 
 Our laboratory has also provided evidence that extracts of somatic cells of one type 
can at least partly reprogram the nucleus of another somatic cell type. Kidney epithelial 
293T cells permeabilized with Streptolysin O (SLO) were exposed to extract of Jurkat T 
cells or primary human T cells (Håkelien et al., 2002; Håkelien et al., 2005; Landsverk et 
al., 2002). Extract-treated 293T cells were shown to acquire T cell functions, such as 
synthesis of IL2 following stimulation of the TCR-CD3 signalling pathway (Håkelien et 
al., 2002; Håkelien et al., 2005). Extract-treated cells also induced expression of T cell-
specific genes, such as induction of IL2 gene expression, and expression of the T cell-
specific cell surface receptors CD3 and CD4 (Håkelien et al., 2002). Downregulation of 
genes encoding fibroblast growth factors, adhesion molecules and cytoskeletal proteins 
was also observed (Håkelien et al., 2002; Håkelien et al., 2005). Furthermore, extract-
treated cells showed some evidence of chromatin remodelling, including histone 
acetylation and uptake of transcriptional regulators of the IL2 gene, demonstrating the 
reprogramming capacity of somatic cell extracts (Håkelien et al., 2002; Landsverk et al., 
2002). Moreover, extracts of cardiomyocytes or insulinoma cells have been shown to elicit 
expression of cardiomyocyte or beta-cell markers in human adipose stem cells (ASCs) 
(Gaustad et al., 2004) and fibroblasts (Håkelien et al., 2004). Permeabilized ASCs exposed 
to rat cardiomyocyte extracts prepared from perfused rat hearts induced expression of 
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several cardiomyocyte markers, including desmin, cardiac troponin I and sarcomeric α-
actinin (Gaustad et al., 2004). Furthermore formation of binucleated and striated cell, as 
well as upregulation of expression of the cell differentiation marker, nuclear lamin A/C, 
provided additional evidence of an ongoing differentiation process induced by extract 
treatment (Gaustad et al., 2004). Moreover, the exposure of permeabilized primary rat fetal 
fibroblast to an extract of INS-1E rat insulinoma cells promoted morphological changes, 
activation of β-cell specific genes and insulin synthesis in the rat fetal fibroblasts (Håkelien 
et al., 2004). More recently, studies have been extended to show that undifferentiated 
human embryonal carcinoma (EC) cells could be used to reprogram 293T cells to take on 
properties of undifferentiated stem-like cells (Taranger et al., 2005). 293T cells exposed to 
EC extract indicated both changes in morphology and upregulation of several genes 
normally expressed in embryos or in EC cells (Taranger et al., 2005). Collectively, these 
studies indicate that cell extracts contain factors essential to elicit at least some form of 
trans- or dedifferentiation in somatic cell of another type. 
 This thesis examines whether the lymphocyte-specific RAG1 and RAG2 genes 
could be induced in human epithelial 293T cells by treatment with an extract of primary 
porcine thymocytes. The results show some indication of transient upregulation of RAG2 









Materials and Methods 
 
Cells 
Human kidney epithelial 293T cells (American Type Culture collection, Manassas, VA) 
were cultured in RPMI-1640 medium (Sigma-Aldrich, St. Louis, MO) containing 10% 
fetal calf serum (Invitrogen, Carlsbad, CA), 2 mM L-glutamine, 1 mM sodium pyruvate 
(Invitrogen, Gibco-BRL, Paisley, UK), non-essential amino acids (Sigma-Aldrich, St. 
Louis, MO) and antibiotics (1% penicillin-streptomycin) (Invitrogen, Gibco-BRL, Paisley, 
UK) (complete RPMI-1640). When approximately 80% confluent, cells were harvested by 
tapping the flask and sub-cultured after a 1:8 or 1:10 dilution. 293T cells treated with 
cellular extracts (see below) were seeded at 10,000 to 40,000 cells per well of a 24-well 
plate (Corning, Corning, NY) and cultured in 700 μl of complete RPMI-1640. Extract-
treated cells were harvested by transferring cell cultures into 24- or 6-well cell plates 
(Corning, Corning, NY) and further passaged by 1:3 to 1:8 dilutions. No trypsinization was 
required for passaging 293T or extract-treated cells. 
 
Isolation of thymocytes from pig thymus 
Pig thymocytes were obtained by isolation from freshly collected pig thymi. Thymi (from 
2-36 hour old piglets) were collected at the Department of Surgical Research at the 
University of Oslo in ice-cold phosphate buffered saline (PBS) in 50 ml plastic tubes. A 
cell sieve (CD1; Sigma-Aldrich, St. Louis, MO) was placed in a 60 mm Petri dish and 
approximately 10 ml of cold complete RPMI-1640 was added to the sieve. The thymus 
was cut in smaller pieces which were placed in the sieve strainer. A cell suspension was 
prepared by pushing the tissue through the mesh with a glass pestle. The cell suspension 
was transferred into a 50 ml tube, centrifuged at 300 g for 10 min at 4oC and washed 4 
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times by suspension and sedimentation in cold PBS. Erythrocytes were lysed by incubating 
the cell suspension in 25 ml of ATC buffer (2.06 g/l Tris Base, pH 7.2, and 7.49 g/l 
NH4Cl). Remaining cells were washed twice in cold PBS. Connective tissue was observed 
as a white aggregate and removed with a pipette. Cells were counted and centrifuged at 
300 g for 10 min at 4oC. PBS was removed and cell pellets were quick-frozen in liquid 
nitrogen and stored at -80oC until use. 
 
Cell extracts 
To prepare a whole cell extract from 293T cells, cells were harvested, washed twice in ice-
cold PBS and once in cell lysis buffer (20 mM Hepes, pH 8.2, 50 mM NaCl, 5 mM MgCl2, 
1 mM dithiothreitol and 1 mM phenylmethylsulfonylfluoride), centrifuged at 300 g, 
resuspended in one volume of cell lysis buffer containing protease inhibitor cocktail 
(Sigma-Aldrich, St. Louis, MO; 10 μl 100x stock solution/ml cell lysis buffer) and 
incubated on ice for 45 min. Two hundred μl cell aliquots were sonicated using a 
Labsonic-M pulse 3-mm diameter probe sonicator (Model Labsonic M, B. Braun Biotech 
International; Melsungen, Germany; 1.5 min, 35% power, 0.4 sec intervals) until all cells 
and nuclei were lysed, as judged by phase contrast microscopy. Lysates were sedimented 
at 15,000 g for 15 min at 4 oC in a fixed angle rotor. The supernatant (extract) was 
transferred to a new 1.5 ml tube and aliquoted into 100 μl in 200 μl tubes, quick-frozen and 
stored at -80oC. Protein concentrations of extracts ranged from 24.6 to 31.98 mg/ml 
(Bradford assay; BioRad, Hercules, CA), pH ranged from 6 to7 and osmolarity was 375-
387 mOsm (measurements from 3 extract batches). 
Thymocyte extracts were prepared from frozen thymocytes isolated as described 
above. Thymocytes were thawed by warming the tube by hand, pellet size was estimated 
and cells were resuspended in one volume of ice-cold cell lysis buffer with protease 
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inhibitor cocktail. The extract was prepared as described for 293T cells. Protein 
concentrations of extracts ranged from 6.25 mg/ml to 22.5 mg/ml, pH ranged from 6 to 7 
and osmolarity was 368-395 mOsm (measurements from 3 extract batches). 
 
Treatment of 293T cells with thymocyte extract 
293T cells were harvested and washed twice in cold PBS and once in cold Hank’s 
Balanced Salt Solution (HBSS, Ca2+/Mg2+-free; Sigma-Aldrich, St. Louis, MO). One 
aliquot of 100,000 cells/100 μl HBSS was prepared for each reprogramming reaction and 
samples were preheated at 37oC for 2 min. 
 
Membrane permeabilization with Streptolysin O (SLO) 
An SLO working solution was prepared by thawing one aliquot of SLO stock (Sigma-
Aldrich, St. Louis, MO; at 100 μg/ml), and diluting it 1:10 in HBSS on ice. One μl of ice-
cold SLO working solution was then added to each tube containing 100,000 cells. This 
produces an SLO concentration of 100 ng/ml. Samples were incubated horizontally for 30 
min in a 37oC water bath and placed on ice. SLO was diluted by adding 100 μl ice-cold 




Following membrane permeabilization, cells were resuspended in 100 μl of thymocyte 
extract of high or low protein concentration, supplemented with an ATP-regenerating 
system (2.5 mM ATP, 62.5 μg/ml creatine kinase and 25 mM creatine phosphate; Sigma-
Aldrich, St. Louis, MO), 125 mM guanosine triphosphate (GTP; Sigma-Aldrich, St. Louis, 
MO) and with a nucleoside trisphosphate mix (1 mM each of ATP, GTP, CTP, UTP; 
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Roche; Basel, Switzerland) in 1.5 ml tubes. Cells were incubated horizontally for 50 min in 
a 37oC water bath, with occasional agitation.  
 
Plasma membrane resealing 
Plasma membranes were resealed following extract treatment by incubation in CaCl2-
containing medium. Complete RPMI-1640 containing 2 mM CaCl2 (Sigma, St. Louis, MO) 
was prepared, preheated to 37oC and 100 μl was added in each tube containing extract-
treated cells. Cells were transferred into a 24-well culture plate, 500 µl of complete RPMI-
1640 with 2 mM CaCl2 were added to each well and cells were incubated for 2 h at 37oC. 
Cell cultures were then observed by phase contrast microscopy to monitor adhesion to the 
bottom of the well. Floating cells and CaCl2-containing medium were removed and 
replaced with complete RPMI-1640 for further culture. Control 293T cells treated with 
293T cell extracts were treated and cultured as above. 
 
Cell pellet preparation 
Cell pellets were prepared for transcription analysis from 0.5–1x106 293T cells exposed to 
thymocyte extract of high or low protein concentration at indicated time periods after 
extract treatment (see Results). Cells were harvested and counted. Appropriate amount of 
cells were transferred to 1.5 ml or 15 ml tube and centrifuged at 1,000 g for 10 min at room 
temperature. Cell pellets were washed once in PBS and centrifuged at 1,000 g for 10 min. 
The supernatant was removed and the cell pellets were quick frozen in liquid nitrogen and 




Total RNA was isolated from cell pellets using a Qiagen RNeasy mini Kit (Qiagen, Hilden, 
Germany) as described by the manufacturer. In short, buffer RLT containing 1% (v/v) 2-
mercaptoethanol was added to the cell pellet and cells were homogenized through a 21-
gauge needle. One volume of 70% ethanol was added and the lysate was homogenized by 
pipetting. The lysate was removed to an RNeasy column and centrifuged at 9,000 g for 15 
sec. The flow through was discarded and the collection tube was replaced. Buffer RW1 
was added to the sample and centrifuged at 9,000 g for 15 sec. The RNeasy column was 
placed into a new collection tube, buffer RPE was added and the sample was centrifuged as 
above. This step was repeated once. The RNeasy column was replaced into a new 
collection tube and centrifuged at 18,000 g for 1 min. The RNeasy column was placed into 
a 1.5 ml tube and 30-50 μl of RNase-free water were added. The sample was centrifuged at 
9,000 g for 1 min.  
 
DNase treatment of RNA  
The RNA preparation was treated with DNase to remove any contaminating genomic 
DNA. We used two protocols for this purpose, 1) DNase treatment in a column (RNase-
free DNase set; Qiagen, Hilden, Germany) and 2) RQ1 DNase treatment (Promega, 
Madison, WI). The first protocol was done during the RNA isolation in the RNeasy 
column. RNA isolation was as described above, until buffer RW1 was added. The sample 
was centrifuged at 9,000 g for 15 sec and 10 µl of DNase I solution (prepared by devolving 
solid DNase (1500 Kunitz units) in 550 µl RNase-free water) mixed with 70 µl Buffer 
RDD was added to the silica-gel. The sample was incubated for 15 min, buffer RW1 was 
added and the sample was centrifuged at 9,000 g for 15 sec. The column was placed into a 
new collection tube, buffer RPE was added and the sample was centrifuged at 9,000 g for 2 
min. The column was replaced into a new collection tube and centrifuged at 18,000 g for 1 
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min. Next, the column was placed into a 1.5 ml tube, 50 μl of RNase free water was added 
and the sample was centrifuged at 9,000 g for 1 min. RNasin (Promega, Madison, WI; 
RNasin® Plus RNase Inhibitor; 2 µl/50 µl RNA) was added to the flow-through. The 
resulting RNA was used as template for cDNA synthesis. 
In the RQ1 DNase treatment, 6 µl RQ1 10x buffer, 2 µl RQ1 DNase and 2 µl of 
RNasin (Promega, Madison, WI; RNasin® Plus RNase Inhibitor) were added per 50 µl 
RNA preparation and the mixture was incubated for 20 min in a 37 oC water bath. After 
incubation, RNA was cleaned up from the DNase reaction by adjusting the sample to 100 
µl with RNase-free water. Next, buffer RLT containing 1% (v/v) of 2-mercaptoethanol was 
added and all reagents were mixed well. 96% ethanol was added to the column and the 
sample was removed to the RNeasy column in a 2 ml collection tube and centrifuged at 
9,000 g for 15 sec. The column was placed into a new collection tube, buffer RPE was 
added and the sample was centrifuged as above. The flow through was discarded, buffer 
RPE added and the sample was centrifuged at 9,000 g for 2 min. The RNeasy column was 
placed into a new collection tube and centrifuged at 18,000 g for 1 min. The column was 
placed into a 1.5 ml tube, 50 µl of RNase-free water was added and the sample was 
centrifuged at 9,000g for 1 min. RNasin (Promega, Madison, WI; RNasin® Plus RNase 
Inhibitor; 2 µl/50 µl RNA) was added to the flow-through. The resulting RNA was used as 
template for cDNA synthesis. 
 
cDNA synthesis 
cDNA was prepared from 1 µg RNA using the iScript™ cDNA synthesis Kit (BioRad, 
Hercules, CA).  Four µl of 5x iScript reaction mix, 1 µl iScript reverse transcriptase, 0-15 
µl nuclease–free water and 1 µg RNA were mixed in a total volume of 20 µl. cDNA 
synthesis without reverse transcriptase was performed to control for the presence of 
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genomic DNA for each RNA preparation. cDNA synthesis conditions were 25oC for 5 
min, 42oC for 30 min and 85oC for 5 min. cDNA samples were stored at -20oC. 
 
Primer design 
Nucleotide sequences for pig (Sus scrofa) RAG1 and RAG2 were obtained from the NCBI 
database using Nucleotide search. Primers specific for pig RAG1 and RAG2 were designed 
using Primer 3 (http://frodo.wi.mit.edu/cgi-bin/primer3/primer3_www.cgi) and Net primer 
(http://www.premierbiosoft.com/netprimer/netprlaunch/netprlaunch.html) programs. The 
Primer 3 program picks out primers from a given DNA sequence and proposes the best 
primer alternatives. The Net primer program analyses primer sequence for dimerization, 
hairpin formation and %CG. Nucleotide sequences for human (Homo sapiens) RAG1 and 
RAG2 were obtained from the NCBI database using Nucleotide search.  Human primers for 
RAG1 and RAG2 were designed using the oligo6-primer design program (htpp://oligo.net). 
Primer sequences used in this study are shown in Table 1 and Figures 1A and 1B. 
 
Homology determination 
The homology between human and pig RAG1 and RAG2 coding sequences and between 
human and pig nucleotide sequences amplified by human and pig RAG1 and RAG2 
primers were determined by two sequence BLAST (Tatusova and Madden, 1999). 
Sequence alignment was generated by this tool using the BLAST engine. 
 
Real-time quantitative RT-PCR 
Real-time quantitative RT-PCR reactions were carried out in triplicates using IQ TM 
SYBRGreen Superscript (BioRad, Hercules, CA) on a BioRad MyCycler Thermocycler. 
Amplification was carried out in a total volume of 25 µl in an Icycler IQ™ PCR 96 well 
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plate (BioRad, Hercules, CA). Reaction mixture was composed of 12.5 µl IQ TM SYBR 
Green supermix (BioRad, Hercules, CA), 1 µl of a primer set (0.4 mM of each primer), 1 
µl of cDNA mixed with 4 µl H2O or Tris-EDTA (TE, pH 7.6) and 6.5 µl H2O. RT-PCR 
conditions were 95oC for 3 min, and 40 cycles of 95oC 30 sec, 60oC 30 sec and 72oC 30 
sec. Melting point analysis started at 65oC, with an increase of 0.5oC every 10 sec up to 
95oC. PCR products were stored at -20oC. The MyiQ Single-Color Real Time PCR 
Detection software was utilized for data analysis. 
 The relative expression levels of human RAG1 and RAG2 in extract treated cells 
compared to untreated 293T cells were calculated from mean threshold cycle (Ct) values 
and PCR effiency of each primer (Pfaffl, 2001). PCR efficiency of each primer pair used 
was determined by the LinREG program (Ramakers et al., 2003). The human 
housekeeping gene GAPDH was used as a reference gene for normalization of data. RT-
PCR primers for human and pig RAG1 and RAG2 and human GAPDH are shown in Table 
1.  
 
Analysis of human RAG1 and RAG2 expression 
In order to investigate RAG1 and RAG2 expression in extract-treated 293T cells, we 
determined the relative expression of RAG1 and RAG2 in untreated 293T cells compared to 
pig thymocytes. cDNA from 293T cells and thymocytes was analyzed in triplicates by 
QRT-PCR using human RAG1 and RAG2 primers. Ratios between human RAG1 and 
RAG2 expression in 293T cells compared to thymocytes were calculated from assumed 
PCR efficiency of 80% (expressed as 1.8 in calculations) raised to the power of difference 
between a mean threshold value (Ct) of one triplicate and a mean threshold value (Ct) of 
another triplicate (1.8 (mean Ct of triplicate 1 – mean Ct of triplicate 2)).  
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Agarose gel electrophoresis 
1.5% agarose gel electrophoresis with ethidium bromide staining was used to visualize RT- 
PCR products. Products were electrophoresed for ~ 20 min at 100 V. Gels were visualized 
using a GEL DOC 2000 system (BioRad, Hercules, CA). Product sizes were determined 

















Framework and objectives of the study 
 
In vitro reprogramming of gene expression may be useful for investigation of processes 
regulating gene expression and for, potentially, producing replacement cells for the 
treatment of a wide variety of diseases (Collas and Håkelien, 2003). The research group of 
Philippe Collas has shown that somatic cell extract can be used to reprogram gene 
expression in differentiated nuclei of permeabilized human epithelial 293T cells. The 
objective of this study was to test the hypothesis that 293T cells could be induced to 
express lymphoid cell-specific RAG1 and RAG2 genes by treatment with extract of 
primary pig thymocytes. Because the large numbers of cells are required to prepare 
reprogramming extract, isolation of thymocytes from pig thymus is therefore a well 
suitable method to obtain cells for reprogramming experiment, offering an unlimited 
access to materials. 
The specific aims of the study were to: 
1. Design quantitative RT-PCR primers for human and pig RAG1 and RAG2 
transcripts. 
2. Isolate thymocytes from pig thymuses and prepare reprogramming extracts from 
these thymocytes. 
3. Examine changes in 293T cell morphology over time after exposure to thymocyte 
extract. 
4. Investigate whether extract of pig thymocytes can induce expression of RAG1 and 






Specificity of human and porcine RAG1 and RAG2 RT-PCR primers 
This work relies on the use of porcine thymocyte extracts to reprogram human epithelial 
293T cells in order to induce RAG1 and RAG2 expression. To this end, we needed a set of 
primers specific for human and pig RAG1 and RAG2 transcripts. RAG1 and RAG2 
sequences were found to be highly homologous between pigs and humans, with a 
homology of 88% for RAG1 and 91% for RAG2. Coding sequences for human and pig 
RAG1 and RAG2 genes are shown in Figures 4A and 4B. To distinguish between human 
and pig RAG1 and RAG2 transcripts, primers for both human and pig RAG1 and RAG2 
were designed using the Primer 3 program (http://frodo.wi.mit.edu/cgi-
bin/primer3/primer3_www.cgi), the Net primer program 
(www.premierbiosoft.com/netprimer/netprlaunch/netprlaunch.html) and the Oligo6 
program (http://oligo.net). Positions of primers designed for this work are shown in Figures 
4A and 4B. Human and pig primers were designed within a common exon, since exon 
spanning primers for human and pig RAG1 and RAG2 sequences gave a too high %CG 
value to be accepted for primer design (a high %CG correlates with low primer 
specificity). Homologies between human and pig sequences amplified by human RAG1 
and RAG2 primers were 93% and 87%, respectively, and those between human and pig 
sequences amplified by pig RAG1 and RAG2 primers were 84% and 90%, respectively. 
Next, we tested the species-specificity of human and pig primers by RT-PCR 
analysis and visualized PCR products by 1.5% agarose gel electrophoresis and ethidium 
bromide staining. Human RAG1 and RAG2 primers amplified PCR products from 293T 
cell cDNA of expected sizes, namely 186 and 147 bp, respectively (Fig. 4C, left panel, 
lanes 1, 2); however, pig primers did not amplify any product from 293T cell cDNA (Fig.  
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P AAAGCAGGATTCCTCCGAGGGGAAACCCTCGCTGGAGCAATCTCCAGCAGTCCTGGACAAGCCTGGTGGTCAGAAGTCAGCCCTGCCTCAACCAGCATTCAAGCCCCATCCAAAGTTTTTAAAGGAATCCCACGAAGATGGGA                                                                                       hRAG1 513L22   
                                                                                                         -------------------►                                    
H AAGCAAGAGGCAAAGCGATCCATCAAGCCAACCTTCGACATCTCTGCCGCATCTGTGGGAATTCTTTTAGAGCTGATGAGCACAACAGGAGATATCCAGTCCATGGTCCTGTGGATGGTAAAACCCTAGGCCTTTTACGAAAG 
P AAGCAAGAGACAAAGCCATCCACCAAGCCAACCTGAGACGTCTCTGCCGCATCTGTGGGAATTCTTTCAACACCACTGGGCACAAGAGAAGGTATCCAGTCCACGGGCCTGTGGATGGTAAAACCCAAGTCCTTTTACGGAAG 
                                                                                                                                  hRAG1 679R20 























        -------------------► 
           pRAG1 7244L19 
H ACGAGACGCTGACTGCCATCCTGAGTCCTCTCATTGCTGAGAGGGAGGCCATGAAGAGCAGTGAATTAATGCTTGAGCTGGGAGGCATTCTCCGGACTTTCAAGTTCATCTTCAGGGGCACCGGCTATGATGAAAAACTTGTG 
P ATGAGACCCTGACGGCCATCCTGAGCCCTCTCATTGCCGAGAGGGAGGCCATGAAGAGCAGCCAGCTAATGCTGGAGATGGGAGGCATCCTCCGGACTTTCAAGTTCATCTTCAGGGGCACCGGATATGATGAGAAACTGGTC                                                                    ◄-------------------               

























              -------------------► 
                  pRAG2 5595L20 
H TGCTACATCATACATTCTTCCAGAACTTCAGGATGGGCTATCTTTTCATGTCTCTATTGCCAAAAATGACACCATCTATATTTTAGGAGGACATTCACTTGCCAATAATATCCGGCCTGCCAACCTGTACAGAATAAGGGTTG 
P CTCTACATCATACATTCTTCCAGAACTTCAAGATGGGCTATCTTTTCATGTCTCCATTGCCAGAAATGATACCATTTATATTTTAGGAGGACACTCACTTGCCAATAACATCCGTCCTGCCAATCTATATAAAATAAGGGTTG 
                                                                                                       ◄----------------- 
                                                                                                         pRAG2 5827R19 
H ATCTTCCCCTGGGTAGCCCAGCTGTGAATTGCACAGTCTTGCCAGGAGGAATCTCTGTCTCCAGTGCAATCCTGACTCAAACTAACAATGATGAATTTGTTATTGTTGGTGGCTATCAGCTTGAAAATCAAAAAAGAATGATC 
P ATCTCCCCCTGGGTAGCCCAGCTGTGACTTGCACAGTCCTGCCAGGAGGAATCTCTGTCTCCAGTGCAATCCTGACTCAAACGAGCAGTGATGAATTTGTTATTGTTGGTGGCTATCAGCTTGAAAATCAAAAAAGAATGGTC 
                                                                                                 hRAG2 1133L24   
                                                                                                                  -----------------------►  
H TGCAACATCATCTCTTTAGAGGACAACAAGATAGAAATTCGTGAGATGGAGACCCCAGATTGGACCCCAGACATTAAGCACAGCAAGATATGGTTTGGAAGCAACACGGGAAATGGAACTGTTTTTCTTGGCATACCAGGAGA 
P TGCAACATCATCTCTTTCAAGGACAACAAGATAGGAATTCATGAGATGGAAACTCCAGATTGGACCCCAGATATTAAGCACAGCAAGATATGGTTTGGAAGCAACATGGGAAATGGAACCGTTTTCCTTGGCATACCAGGAGA 
                                                                                                   hRAG2 1255R25 








P CTGCAAGGAGCATGTGGAGATAGCAAGAGCACTGCAAACCCCCAAAAGAGTTTTACCCTTAAAAAAGCCTCCACTGAAATCCCTCCACAAAAAAGGTTCTGGGAAAATTATTACCCCTGCCAAGAAATCCTTTCTTAGAAGAT  
H TGTTTGATTAG 
P TATTCGATTAG 







4C, left panel, lanes 3, 4). Human RAG1 and RAG2 primers also amplified PCR products 
from pig thymocyte cDNA with expected sizes (186 and 147 bp, respectively; Fig. 4C, 
right panel, lanes 5, 6). Pig RAG1 and RAG2 primers also amplified products of expected 
size (222 bp and 251 bp, respectively) from thymocyte cDNA (Fig. 4C, right panel, lanes 
7, 8). These results indicate that whereas the human primers detect both human and porcine 
transcripts, the pig primers are pig-specific. 
Verification of this contention was provided by analysis of melting curves. Figure 
4D shows the melting curve analysis for RT-PCR products shown in Figure 4C. Since each 
nucleotide sequence has a characteristic melting temperature, melting curves can be used  
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Figure 4. Specificity of human and pig RAG1 and RAG2 QRT-PCR primers. (A) Human (h, black) and 
pig (p, green) RAG1 nucleotide sequences. Position of the human and pig RAG1 primers is indicated by 
dotted arrows (hRAG1 and pRAG1, respectively). Human and pig RAG1 GeneBank accession numbers are 
NM_000448 and AB091392, respectively. (B) Human (h, black) and pig (p, green) RAG2 nucleotide 
sequences. Position of the human and pig RAG2 primers is indicated by dotted arrows. Human and pig RAG2 
GeneBank accession numbers are NM_000536.1 and AB091391.1, respectively. (C) Agarose gel 
visualization of QRT-PCR analysis of primer specificity. Left, QRT-PCR analysis of RAG1 and RAG2 
transcripts from 293T cells using human (h) and pig (p) primers. Right, QRT-PCR analysis of RAG1 and 
RAG2 transcripts from thymocytes using human (h) and pig (p) primers. (D) Melt curve analysis of 
quantitative RT-PCR products shown in (C). Left, melting curves for QRT-PCR products from 293T cell 
cDNA amplified with human RAG1 (red) and RAG2 (green) primers . Pig primers gave no products. Right, 
melting curves for QRT-PCR products from thymocyte cDNA amplified with human RAG1 (red), RAG2 
(green) and pig RAG1 (blue) and RAG2 (purple). 
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to determine whether samples contain non-specific products (e.g., primer dimers). 293T 
cDNA amplified with human RAG1 and RAG2 primers gave RT-PCR products with  
melting temperatures of 86.6oC for human RAG1 and 80.5oC for human RAG2 (Fig 4D, 
left panel hRAG1 [red] and hRAG2 [green]. Based on these data, we used melting 
temperatures for human RAG1 and RAG2 as an indication of specific QRT-PCR products 
when 293T cDNA was amplified with the human RAG1 and RAG2 primers. Thymocyte 
cDNA amplified with human RAG1 and RAG2 primers gave PCR products with similar 
melting temperatures as with 293T cDNA (RAG1 [red], 87oC; RAG2 [green]: 80.5oC, Fig 
4D, right panel). This indicates that human RAG1 and RAG2 primers also amplify specific 
products from thymocyte cDNA. Pig RAG1 and RAG2 primers with thymocyte cDNA 
amplified products with melting temperatures of 88.5oC for RAG1 and 83.0oC for RAG2 
(Fig. 4D, right panel, RAG1 [blue] and RAG2 [purple]). We used the melting temperatures 
of pig RAG1 and pig RAG2 to specifically verify amplification of pig RAG1 and RAG2 
transcripts. These melting curve analyses indicate that human primers amplify specific 
products with characteristic melting temperatures from 293T and thymocyte cDNA. Pig 
primers amplify only thymocyte cDNA giving PCR products with characteristic melting 
temperatures that reflect pig RAG1 and RAG2 transcripts. Furthermore, none of the QRT-
PCR products were shown to contain non-specific products.   
Altogether, these results indicate that the human RAG1 and RAG2 primers can 
amplify both human and pig transcripts, whereas the pig primers are specific for pig 
transcripts. Therefore, human primers were used in this study to detect any upregulation or 
activation of human RAG1 and RAG2 genes in 293T cells exposed to thymocyte extract, 
but only when used in addition to pig primers. Indeed, pig primers were used to determine 
whether the mRNA preparation of extract-treated 293T cells contained pig RAG mRNA of 
extract origin. 
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Relative levels of RAG1 and RAG2 expression in 293T cells and pig thymocytes 
To investigate the induction of RAG1 and RAG2 expression in 293T cells exposed to 
thymocyte extract, we determined the relative levels of RAG1 and RAG2 expression in 
untreated 293T cells compared to thymocytes, using human RAG1 and RAG2 primers. 
Ratios of RAG1 and RAG2 expression in 293T cells relative to thymocytes were calculated 
from a calculated PCR efficiency of 80%. Figures 5A and 5B indicate that RAG1 and 
RAG2 were expressed 22- and 238-fold higher, respectively, in thymocytes compared to 
293T cells. Melting curve analysis provided correct melting temperatures for the QRT-
PCR products (Fig. 5C). Although RAG1 and RAG2 expression was detected in 
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Figure 5. Relative levels of RAG1 and RAG2 expression in 293T cells and pig thymocytes. (A) 
Quantitative RT-PCR analysis of RAG1 and RAG2 transcripts from 293T cells (green and purple, 
respectively) and from pig thymocytes (red and blue, respectively), using human primers. (B) Histogram 
representation of relative expression levels of RAG1 and RAG2 in 293T cells (level 1) and in pig thymocytes 
(purple bars). (C) Melt curve analysis of QRT-PCR results shown in (A).  
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293T cells, the differences were such that we rationalized that human RAG1 and RAG2 




Preparation of reprogramming extracts from pig thymocytes. 
We prepared whole cell extracts from 293T cells and pig thymocytes. The approach for 
extract preparation from pig thymocytes is illustrated in Figure 6. Particular attention was 
paid to completely lyse all cells by sonication, so that no remaining thymocytes would 
contaminate extracts (assessed by phase contrast microscopy). The procedure developed 
for thymocyte extract preparation is provided in the Materials and Methods.  
Since human RAG1 and RAG2 primers detect both 293T and thymocyte cDNA, 
any upregulation of RAG1 and RAG2 in extract-treated cells (see below) could possibly be 
caused by the uptake of pig RAG1 and RAG2 transcripts from the extract. To examine this 










Figure 6. Schematic illustration of extract preparation from pig thymocytes. Thymus was collected and 
thymocytes were immediately isolated from fresh thymus. Extract was prepared from frozen thymocytes by 
incubation in cell lysis buffer (CLB) with protease inhibitor cocktail and further sonication. Finally, extract 
(supernatant) was obtained after sedimentation at 15,000 g.   
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RAG1 and RAG2 transcripts. No pig transcripts were observed in thymocyte extracts (Fig. 
7). Thus, any alterations in RAG1 and RAG2 expression which might be detected in 
extract-treated cells would most likely not result from RAG1 and RAG2 transcripts uptake 




Figure 7. Quantitative RT-PCR analysis of  RAG1 and RAG2 mRNA in thymocyte extracts. 
Quantitative RT-PCR analysis of pig RAG1 (red) and pig RAG2 (green) transcripts in thymocyte extracts (6 
mg/ml and 22 mg/ml of protein). In QRT-PCR analysis, each sample was analyzed in triplicates. No RAG1 
or RAG2 transcripts were found in thymocyte extracts. 
 
Reprogramming of 293T cells with thymocyte extracts  
In order to determine whether 293T cells could be reprogrammed to induce RAG1 and 
RAG2 expression, cells permeabilized with the pore-forming toxin Streptolysin O (SLO) 
were exposed for 50 min to thymocyte extract of low (6 mg/ml protein) or high (22 mg/ml 
protein) protein concentration. The experimental set up is illustrated in Figure 8. After 
extract treatment, plasma membranes were resealed and extract-treated cells were cultured 
for up to four weeks. Inductions of any reprogramming event were assessed by 
morphological changes and by QRT-PCR analyses of RAG1 and RAG2 expression. 
Untreated 293T cells and 293T cells exposed to a 293T cell extract were used as controls 
for permeabilization and handling effects.   
As a first indication of any change occurring in 293T cells following thymocyte 








Figure 8. Experimental set up of in vitro cell reprogramming. 293T cells are permeabilized with 
Streptolysin O (SLO) and incubated in thymocyte extract. After incubation, cell membranes are resealed with 
2 mM CaCl2 after diluting the extract and cell mixture with complete RPMI-1640 medium. Over time period 
of 4 weeks, extract-treated cells were analysed for changes in morphology and induction of human RAG1 and 
RAG2 expression by real time RT-PCR. (Modified from Collas and Håkelien, 2003). 
 
that, like untreated 293T cells (Fig. 9A), 293T cells treated with a control 293T cell extract 
or with thymocyte extract continued to grow as adherent cells with a fibroblastic 
morphology (Fig. 9B-D). Cell morphology was not affected by extract concentration and 
by duration of cultured after exposure to the extracts (Fig. 9C,D). The doubling time of the 
cells also remained unaltered (data not shown). We concluded that, unlike treatment with 
Jurkat cell extract (Håkelien et al., 2002; Håkelien et al., 2005), thymocyte extract 
treatment under these conditions had no obvious effect on growth pattern and morphology 
of 293T cells. 
 
Expression of human RAG1 and RAG2 in extracts-treated cells 
Despite the lack of noticeable morphological changes, we investigated whether expression 
of RAG1 and RAG2 was altered in 293T cells as a consequence of extract treatment. 
Expression of the housekeeping GAPDH gene was used for normalization of expression. 
Expression levels of RAG1 and RAG2 in all samples were calculated relative to those in  
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 Figure 9. Morpology of 293T cells and of 293T cells treated with thymocyte or 293T cell extract and 
cultured for up to four weeks. (A) Untreated 293T cells. (B) 293T cells treated with 293T extract. (C,D) 
293T cells treated with thymocyte extract of low protein concentration (C; 6 mg) and of high protein 
concentration (D; 22 mg). Magnification, (A) 100x, (B-D) 200x.  
 
untreated 293T cells (“level 1”). Cells were analyzed by QRT-PCR at 8, 13 and 31 days 
after extract treatment. As the primers designed lie within exons (see above), total RNA 
was purified and digested with DNase to reduce the extent of putative contamination with 
genomic DNA. Relative expression levels of RAG1 and RAG2 in thymocyte and 293T 
extract-treated cells are shown in Figures 10A and 10B. 293T cells exposed to thymocyte 
extracts of low protein concentration (6 mg/ml) or to 293T extract showed less than 2-fold 
upregulation of RAG1 expression relative to untreated 293T cells at all times (Fig. 10A, 
left and right panels). RAG2 expression also remained relatively unaltered under these 
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Figure 10. Quantitative RT-PCR analysis of human RAG1 and RAG2 expression in extract-treated 
293T cells relative to input 293T cells (“level 1”). Relative expressions (fold) of (A) RAG1 and (B) RAG2, 
in 293T cells treated with thymocyte extract of low and high protein concentration (6 mg and 22 mg, 
respectively) and with 293T extract. Expression levels were normalized with human GAPDH in triplicate 
analyses. No significant up regulation of human RAG1 or RAG2 were observed in 293T cells exposed to 
thymocyte (6 mg/ml) and 293T extracts. 293T cells treated with thymocytes extract (22 mg/ml) showed up 
regulation of RAG2 8 days after extract treatment. (C) Relative expression of human RAG1 (blue bars) and 
RAG2 (yellow bars) in thymocyte extract (22 mg) treated cells at indicated time points after extract treatment. 
Expression levels in extract treated cells were relative to untreated 293T cells (purple bar, level 1 for both 
human RAG1 and RAG2). Human RAG2 was up regulated approximately 3.7-fold after 8 days. (D) QRT-
PCR analysis with pig RAG1 and RAG2 (red and green, respectively) on thymocyte extract (22 mg/ml) 
treated 293T cells, 8 days after extract treatment. No pig transcripts of extract origin were detected in mRNA 
preparation of extract treated 293T cells.  
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upregulation of RAG2 by 13 days and expression levels close to baseline at other time 
points (Fig. 10B, left and right panels). Similarly, treatment with high-protein extracts (22 
mg/ml) caused a ~2-fold upregulation of RAG1 expression by 13 days, and only minor 
alterations at other time points (Fig. 10A, middle panel). In contrast, RAG2 upregulation 
was clearly detected 8 days after extract treatment (3.7-fold upregulation; Fig. 10B, middle 
panel). After 13 days, RAG2 levels were 2.3- fold upregulated compared to baseline and by 
31 days expression had returned close to that of untreated 293T cells (Fig. 10B, middle 
panel). RAG1 and RAG2 expression levels in 293T cells exposed to thymocyte extract of 
high protein concentration relative to input 293T cells are summarized in Figure 10C.  
We determined in a previous experiment that thymocyte extracts did not contain 
any detectable RAG1 or RAG2 transcripts (see Fig. 7), ruling out the possibility of 
contamination of permeabilized 293T cells with RAG transcripts of extract origin. To 
further rule out this unlikely possibility, extract-treated 293T cells were analyzed by QRT-
PCR using pig RAG1 and RAG2 primers, which are specific for pig transcripts and do not 
detect human products (see Fig. 4). As expected, the results indicate that no pig RAG1 or 








Figure 11. Genomic control for thymocyte extract treated 293T cells. None of the primer pairs used gave 
products on the genomic control for thymocyte extract treated cells. hGAPDH (orange), hRAG1 (red), 
hRAG2 (green), pRAG1 (blue) and pRAG2 (pink). Pig RAG2 was detected at cycle 36 (green line) and was 
considered to be non-specific. 
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treatment (Fig. 10D). These data strongly suggest that upregulation of RAG2 detected in 
293T cells exposed to thymocyte extract results from induction of the 293T cell genome. 
The peak of RAG2 expression observed at day 8 decreased to baseline within 23 days. 
Thus, induction of RAG2 expression was transient and not sustained over the four weeks 
examined. This observation is reminiscent of previous data reported in other similar 
extract-based systems (Gaustad et al., 2004; Håkelien et al., 2004 see Discussion). 
Lastly, to determine whether the mRNA preparation analyzed in the previous 
experiment contained any genomic DNA, cDNA synthesis without reverse transcriptase 
was used to prepare a genomic DNA control for total RNA isolated from thymocyte 
extract-treated cells (8 days after extract treatment). The RNA preparation was found not to 
contain any genomic DNA (Fig. 11). This observation reinforced our conclusion that 
RAG2 was upregulated in cells exposed to thymocyte extract of high protein concentration, 
















This thesis evaluates the capacity of cellular extracts of pig thymocytes to induce the 
expression of two lymphoid-specific genes, RAG1 and RAG2, in human epithelial 293T 
cells. As such, RAG1 and RAG2 are used as markers for functional changes in 293T cells, 
which may be qualified as transdifferentiation events. Real time RT-PCR analysis provided 
a quantitative method to detect alterations in RAG1 and RAG2 expression levels from 
relatively small amounts of total mRNA. Furthermore, we investigated whether extract 
treatment affected the morphology of 293T cells. Results from QRT-PCR analysis show 
upregulation of RAG2 in 293T cells exposed for 50 min to thymocyte extract of high 
protein concentration, but no clear upregulation of RAG1. Moreover, thymocyte extract 
treatment showed not to affect the morphology of 293T cells. 
 
Homology between human and porcine RAG sequences: implications for 
transcriptional regulation of RAG1 and RAG2 
Earlier studies have shown conservation of RAG1 and RAG2 genes in variety of species 
that carry out V(D)J recombination (Oettinger et al., 1990; Schatz et al., 1989). Based on 
these reports, we expected to find a high homology between human and porcine RAG1 and 
RAG2 coding sequences. The sequence alignment by two-sequence BLAST (Tatusova and 
Madden, 1999), that assigns the homology of  two sequences by local alignment using a 
BLAST engine, showed homology between human and pig RAG1 and RAG2 coding 
sequences to be 88% and 91%, respectively. Although little is known about transcriptional 
regulators or other mechanisms that regulate RAG1 and RAG2 gene expression, we 
assumed from the high coding sequence homology and RAG gene conservation between 
species that the RAG1 and RAG2 genes would be regulated by similar factors in different 
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species. Further, to attempt to determine if these genes have similar regulation patterns in 
human and pig, we could have determined the homology between pig and human RAG1 
and RAG2 regulatory regions and looked for conserved regions that might be involved in 
regulation of these genes. However, earlier reprogramming studies involving two species 
have shown that it is possible to use extract of one species (rat) to reprogram cells of 
another species (human) (Gaustad et al., 2004). Thus, we hypothesized that pig thymocyte 
extract could be used to reprogram 293T cells. 
 
Extracts 
Several studies have shown that treatment of donor cell type (e.g., 293T cell) with a 
‘target’ cell type (e.g., Jurkat cell) extract favors the establishment of a target cell- specific, 
although perhaps not complete, transcriptional program (Gaustad et al., 2004; Håkelien et 
al., 2002; Håkelien et al., 2005; Taranger et al., 2005). Although extracts are believed to 
contain factors essential for establishment of new transcriptional program in reprogrammed 
cells, the nature of these factors remains to be identified. Nonetheless, preliminary studies 
indicate that in the Jurkat T cell or embryonal carcinoma systems (Håkelien et al., 2002; 
Taranger et al., 2005), DNase or RNase treatment of extracts does not apparently affect 
phenotypic or gene expression changes in extract-treated cells. To which extent this 
contention can be generalized to complete morphological and functional reprogramming, 
however, is uncertain. Furthermore, trypsin, protease or heat treatment of extracts abolish 
gene expression induced by extract exposure (Taranger et al., 2005). In addition, recent 
studies from our laboratory and others have shown that the ATPase chromatin remodeling 
factor Brg1, a component of the SWI/SNF chromatin remodeling complex (Khavari et al., 
1993; Klochendler-Yeivin et al., 2002) was essential for induction of expression of the 
embryonic transcription factor OCT4 (Hansis et al., 2004; Taranger et al., 2005). Lastly, 
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there is a dose-dependent requirement for exogenous energy sources in the extract, as 
ATP-depletion, or substitution of ATP or GTP with non-hydrolyzable analogues abolishes 
reprogramming of gene expression (Taranger et al., 2005).  
Our work was based on earlier studies showing reprogramming capacity of human 
primary T cells or Jurkat cell extracts to induce transdifferentiation in 293T cells (Håkelien 
et al., 2002; Håkelien et al., 2005; Landsverk et al., 2002). The thymus is the organ where 
T cells differentiate and mature from T cell progenitors, or thymocytes. Because 
thymocytes undergo TCR gene rearrangement during maturation, they contain factors 
essential for these functions. Consequently, thymocyte extracts would be expected to 
contain components required for activating the RAG1 and RAG2 genes.  
To support this view, our results indicate that 293T cells exposed to thymocyte 
extract can upregulate RAG2 expression (RAG1 expression is not upregulated in our study, 
however one cannot exclude the possibility that this event is impossible). This result 
suggests therefore two possibilities. First, RAG gene-activating factors are taken up by the 
permeabilized 293T cells and imported into the nucleus where they activate their target 
genes (the extract supports active nuclear-cytoplasmic transport; Landsverk et al., 2002). 
Alternatively, and not exclusively, RAG gene transcriptional regulators are being activated 
and/or induced to be synthesized by 293T cells in order to induce endogenous RAG1 and 
RAG2 expression. The latter view is supported by the time interval required to detect 
RAG2 upregulation in our current system; however, we have at present no experimental 
evidence to conclude one way or the other. Only RT-PCR analysis using species-specific 
primers suggests that upregulation/activation of endogenous RAG2, at least, occurs in 293T 
cells upon treatment with thymocyte extract.  
RAG2 induction in our system was shown to be due to extract treatment and not 
caused by RAG2 mRNA of extract origin or genomic DNA contamination. In addition, 
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because no upregulation was detected in 293T cells exposed to low protein thymocyte 
extract, our results also suggest that protein concentration in the extract is an essential 
factor for successful reprogramming events. 
 
Induction of gene expression in thymocyte extract 
Three macro- or microarray-based gene expression analyses of extract-treated 293T cells 
strongly suggest that whole cell extracts, such as those developed here, are more efficient 
at inducing transcription or upregulation of transcription than gene repression or 
downregulation (Håkelien et al., 2002; Håkelien et al., 2005; Taranger et al., 2005). This 
observation may presumably be due to nature of extract. The system used in our laboratory 
supports the maintenance of a reorganized (e.g., hyperacetylated chromatin; Landsverk et 
al., 2002) yet decondensed interphase chromatin structure. This is in contrast to mitotic cell 
extract-based protocols developed that promote a condensed and repressive chromosome 
configuration (Sullivan et al., 2004).  
 How could one, then, promote enhanced reprogramming of gene expression? 
Conceivably, 293T cells, or any cell to be reprogrammed, may be induced to first undergo 
a step of nuclear breakdown (mitotic-like) and chromosome condensation in a mitotic 
extract (Sullivan et al., 2004). Presumably owing to protein phosphorylation events, this 
step promotes the dissociation of transcriptional regulators from the donor cell (Sullivan et 
al., 2004). As a result, gene activity would be reduced. In a second step, cells harboring 
condensed chromosomes may be triggered to undergo nuclear reconstitution (such as that 
occurring upon exit from mitosis), with associated chromatin decondensation and 
activation of novel genes as a result of exposure to reprogramming molecules of extract 
origin. Although this two-step reprogramming has not formally been tested, collaborative 
work between our laboratory and Hematech LLC (a private corporation based in Sioux 
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Falls, SD, USA) has shown that purified human somatic nuclei can be induced to undergo 
chromosome condensation in extracts of metaphase II bovine oocytes. Further, upon 
reentry of extracts into interphase (promoted by exogenous calcium), the nuclei 
decondense, reform a nuclear envelope and replicate DNA (P. Collas and P. Kasinathan; 
personal communication). Thus, it would in principle be possible to carry out a two-step 
reaction to enhance reprogramming of gene expression.  
Perhaps the most argumentative rationale to support this view is the successful 
reprogramming of nuclear function in somatic nuclei following transplantation into 
enucleated metaphase II oocytes. Interestingly, transplanted nuclei invariable undergo a 
step of breakdown and chromatin condensation in the oocyte before being reformed with a 
completely new morphology (pronucleus-like) after activation of the recipient oocyte in 
order to promote embryo development (Lemaitre et al., 2005; Sullivan et al., 2004).  
  
Why RAG2 and not RAG1? Insights into chromatin organization 
The two lymphoid-specific genes RAG1 and RAG2 are located on the same chromosome 
and only 8 kilobases apart from each other in human (Oettinger et al., 1990). During the T 
cell (or B cell) development, RAG genes are transcribed convergently to produce products 
that mediate V(D)J recombination of antigen receptor genes (Oettinger et al., 1990). 
Furthermore, little is still known about the mechanisms that regulate RAG1 and RAG2 
expression. Tissue- and stage-specific regulation of the RAG1 gene is thought to be 
controlled through changes in chromatin structure and by cis-acting elements outside the 
RAG1 promoter region (ranging from -2.7 kb to +50 kb) (Kitagawa et al., 1996; Kurioka et 
al., 1996). Also Rag2 gene expression is shown to be regulated by alterations of chromatin 
structure, in addition to regulation by cis-regulatory elements (Wei et al., 2002). A 
lymphoid cell line-specific enhancer (D3) has been found at the distal promoter region of 
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Rag2. The C/EBP transcriptional regulator is predicted to bind to this enhancer and 
therefore might functions as transcriptional factor responsible for enhancer activity (Wei et 
al., 2002). Rag2 promoter activity has also been activated by Pax-5 (in B cells) and GATA-
3 (in T cells) transcriptional factors in lymphoid cell lineages (Kishi et al., 2000). 
 Coordinate transcription of RAG1 and RAG2 genes during V(D)J recombination 
suggests that common regulatory elements might be involved in controlling the expression 
of these two genes. However, no such elements have yet been identified. Nevertheless, 
regulation of chromatin structure is shown to be involved in gene expression control of 
both RAG1 and RAG2 (Kitagawa et al., 1996; Kurioka et al., 1996; Wei et al., 2002). As 
we have only observed upregulation of the RAG2 gene in our experiments, we hypothesize 
that chromatin structure has been changed to enable RAG2 activation or upregulation. 
Furthermore, as no significant changes of RAG1 expression was observed, this presumes 
that RAG1 transcriptional control regions are either repressed by chromatin structure or by 
binding of specific inhibitory regulatory elements, or that RAG1-activating factors are 
absent or present below a threshold concentration. However, to prove these predictions, we 
would need to further investigate the chromatin structure of RAG1 and RAG2 genes as a 
result of thymocyte extract treatment.  
Chromatin structure can be altered by chromatin remodeling complexes that use the 
energy of ATP hydrolysis to change the structure of nucleosomes. Furthermore, chromatin 
structure can be affected by covalent modification of N-terminal tails of histones, for 
example by acetylation, methylation, phosphorylation and ubiquitination. Acetylation of 
histone H3 on lysine 9 (H3K9) is generally associated with trancriptionally active 
chromatin (Sims, III et al., 2003). In contrast, H3K9 methylation is associated with a 
repressed chromatin state and gene inactivation (Sims, III et al., 2003). There is now 
evidence showing that some activation of chromatin remodeling complexes and acetylation 
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of histones can be induced in 293T cell by extract treatment (Håkelien et al., 2004; J.A. 
Dahl and C.K. Taranger in our laboratory; unpublished data). Thus, to determine if 
induction of RAG2 expression detected in 293T cells exposed to thymocyte extract was 
due to changes in chromatin structure, it would be interesting to investigate the RAG2 gene 
regulatory regions for histone acetylation or methylation.  Chromatin immunoprecipitation 
(ChIP) procedures suitable for investigation of the H3K9 and H3K4 modification are being 
used in our laboratory. Thus, in the future, ChIP can be used to further determine the 
chromatin organization status of the RAG1 and RAG2 gene promoters before and after 
thymocyte extract treatment. In addition, because gene expression is also largely regulated 
by DNA methylation status in the promoter and/or enhancer regions (Doerfler, 2005; Fuks, 
2005), another possibility is to assess DNA methylation changes occurring after extract 
treatment. Interestingly, such procedures (e.g., bisulfite sequencing analysis) are also being 
routinely used in our laboratory. Therefore, a logical follow up of the present work would 
consist in an epigenetic analysis of (mis)regulation of RAG1 and RAG2 genes in 293T cells 
as a result of thymocyte extract treatment.  
 
Transient versus long term gene expression in extract-treated cells 
Changes in gene expression patterns in extract-treated cells have been shown in our 
laboratory to be either short-lived (1-3 weeks; (Gaustad et al., 2004; Håkelien et al., 2004)) 
or more long-lived (at least several months;  (Håkelien et al., 2002; Håkelien et al., 2005; 
Taranger et al., 2005)). The transient upregulation of RAG2 detected in our study is 
consistent with these observations of Håkelien et al. (2004) and Gaustad et al. (2004). 
RAG2 expression was detected by 8 days of extract-treatment and decreased to baseline by 
23 days.  
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 RAG1 and RAG2 genes are lymphoid cell specific and thought to be solely 
expressed in immature T cells (and B cells). RAG1 and RAG2 are essential for T cell 
development and therefore were thought to be reliable markers of nuclear reprogramming. 
However, RAG1 and RAG2 were shown to be expressed also in untreated 293T cells (see 
Results). Fortunately, the level of expression observed was much lower than in 
thymocytes. From the differences in expression levels we rationalized that these genes 
could be used as a marker for transdifferentiation in our work. Furthermore, RAG1 and 
RAG2 are shown to be expressed at low levels in naïve CD4+ T cells, activated/memory 
CD4+ T cells and germinal center T cells in human tonsils (Li et al., 2002). These 
observations suggest that RAG1 and RAG2 are not exclusively expressed in immature T 
cells, but also expressed at lower levels in peripheral T cells.  
Transient upregulation of RAG2 in 293T cells may simply be a consequence of 
largely incomplete reprogramming. This view is supported by the lack of morphological 
reorganization of cellular architecture after extract treatment (see above). Alternatively, 
transient RAG2 upregulation may be accounted for by the ‘two-wave’ expression pattern of 
RAG1 and RAG2 in vivo. In thymocytes, RAG1 and RAG2 are upregulated at the TN stage, 
after which their expression is downregulated and again reinduced in the DP stage. Thus, 
RAG1 and RAG2 expression is not sustained, but altered in a way that correlates the 
rearrangements of TCRαβ genes in developing thymocytes. Furthermore, RAG1 and RAG2 
expression is terminated upon positive selection and generally not detected in cells after 
this stage of development. As such, we expected to detect RAG1 and RAG2 expression that 
would alter and finally be repressed after a period of time. The challenge that lies in the 
detection of gene expression pattern that alters over time is to manage to detect the ‘tops’ 
where these genes are most actively expressed. We have analyzed expression of RAG1 and 
RAG2 at 8, 13 and 31 days after extract treatment. Further, we might assume that the 
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expression levels of these genes could have altered at other time points and therefore it is 
possible that we have not been able to detect the ‘actual’ upregulation of RAG1 and RAG2.  
Would it be possible to detect TCR gene rearrangement in 293T cells treated with 
thymocyte extract? It would have been interesting to investigate the extract treated 293T 
cells for TCR gene rearrangements. The central portion of the RAG1 protein contains 
nonamer (conserved sequence of 9 nt that is part of RSS) binding domain (NBD) through 
which initial recognition of the RSS proceeds (Aidinis et al., 1999; Difilippantonio et al., 
1996). RAG2 has shown no apparent affinity for the RSS; however, it interacts with RAG1 
and may have a role in coordinating multiple protein-protein interactions at the RSS 
(Aidinis et al., 2000; Corneo et al., 2000). RAG1 alone has also been shown to inefficiently 
induce V(D)J recombination in fibroblasts, but when cotrasfected with RAG2 the 
frequence of recombination was increased 1000-fold (Oettinger et al., 1990). Thus, based 
on these data we might expect that both RAG1 and RAG2 are equally needed for 
successful TCR gene rearrangements through V(D)J recombination. Clearly, if 
rearrangements of TCR genes had been detected in extract-treated cells, these would have 
indicated RAG1 and RAG2 expression in extract-treated cells at other time points than 
selected. Furthermore, as we have only observed RAG2 upregulation in the 293T cells, we 
did not expect to find any TCR rearrangement. Clearly, rearrangement of TCR genes 
remains to be investigated in our experimental system. 
 Reprogramming a somatic cell to induce RAG1 and RAG2 expression with 
subsequent TCR gene rearrangement and TCR molecule assembly would potentially have 
tremendous medical benefits. Mutation in either RAG1 and RAG2 genes has been shown to 
cause immune deficiencies in human (e.g., Omenn disease; Villa et al., 1998; Villa et al., 
2000). Moreover, reprogramming a somatic cell type towards T lymphocytes could be used 
to enhance immune system of cancer patients with low level of T lymphocytes. Related 
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reprogramming technologies might also be useful to re-educate the thymus in order to 
make the immune system tolerant to exogenous (transplanted) cells or organs, or to instruct 
the immune system not to attack self-antigens in the case of autoimmune diseases.  
 
Conclusion 
This thesis provides a first step towards determining the capacity of pig thymocyte extracts 
to reprogram nuclear function in non-lymphoid cells. Upregulation of RAG2 was observed 
in 293T cells exposed to thymocyte extract, indicating that, presumably, some nuclear 
reprogramming events have taken place. RAG2 upregulation, however, was transient, 
suggesting that nuclear reprogramming was incomplete (a most likely possibility); 
alternatively, the pattern of RAG2 expression may be accounted for by the nature of RAG1 
and RAG2 gene expression profiles in maturing thymocytes. At this stage of the project, 
more work is clearly required to (i) improve the reprogramming effects of thymocyte 
extracts, (ii) enhance the extent and duration of RAG2 upregulation, (iii) promote RAG1 
expression in extract-treated cells. Only then will one be able to investigate any functional 
significance of inducing the RAG enzymes, by determining whether TCR gene 
rearrangement takes place. Therefore, additional evidence is needed to establish a proof-of-
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Table 1. Human (h) and pig (p) RAG1 and RAG2 and human GAPDH QRT-PCR primers. 
 
 
 
 
 
L-primer 
 
R-primer 
 
Expected 
 product 
 
hRAG1 
 
ATGGTCCTGTGGATGGTAAAAC 
 
ATGGGGCACTGCTAAACTTC 
 
 
186bp 
 
hRAG2 
 
ATGGAACTGTTTTTCTTGGCATAC 
 
CTGGATCTTCTGTTGATGTTTGACT 
 
 
147bp 
 
pRAG1 
 
CGTTCGGTTTTCCTTCACA 
 
 
CCTCCCATCTCCAGCATTAG 
 
 
222bp 
 
pRAG2 
 
CGAGGGAAAAGTATGGGTGT 
 
 
GCAGGACGGATGTTATTGG 
 
 
251bp 
 
 
 
hGAPDH 
 
TCGGAGTCAACGGATTTGGT 
  
TTGCCATGGGTGGAATCATA 148bp 
  
 62
